Specialty Chemicals in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Europe specialty chemicals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
*The specialty chemical market covers the revenues generated from the sales of high value-added chemicals used in the manufacture of a wide variety of products, including but not limited to fine chemicals, additives, advanced polymers, adhesives, sealants and specialty paints, pigments and coatings.
*The European specialty chemicals market had total revenue of $212.3 billion in 2010, representing a compound annual growth rate (CAGR) of 2.6% for the period spanning 2006-2010.
*Fine chemicals sales proved the most lucrative for the European specialty chemicals market in 2010, with total revenues of $88.8 billion, equivalent to 41.8% of the market's overall value.
*The performance of the market is forecast to accelerate, with an anticipated CAGR of 4.7% for the five-year period 2010-2015, which is expected to drive the market to a value of $266.9 billion by the end of 2015.
Features
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the specialty chemicals market in Europe
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the specialty chemicals market in Europe
Leading company profiles reveal details of key specialty chemicals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Europe specialty chemicals market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Europe economy
Key Questions Answered
What was the size of the Europe specialty chemicals market by value in 2010?
What will be the size of the Europe specialty chemicals market in 2015?
What factors are affecting the strength of competition in the Europe specialty chemicals market?
How has the market performed over the last five years?
What are the main segments that make up Europe's specialty chemicals market?
Introduction
Chemical Manufacturing in South America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metri ... more
Introduction
Chemical Manufacturing in Eastern Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metr ... more
Introduction
Chemical Manufacturing in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metri ... more
As pay-for-delay agreements look to be on the way out of the pharmaceutical industry in Europe and the US, a new report by independent market analyst Datamonitor forecasts that the number of authorized generics (AG) agreements will grow, in tandem with the increasing convergence between bra ... more
As part of the UK government’s drive to save £2.3 billion ($3.4 billion) in the National Health Service (NHS) during 2010–11, £550m ($800m) will be cut from the prices of branded drugs as a result of the revised Pharmaceutical Price Regulation Scheme (PPRS) included in Alistair Darling’s 20 ... more
In recent years, Pharma has begun to adapt its business model in response to growing industry constraints and the decline of primary-care focused blockbuster therapy. This process of change has recently been disrupted by unprecedented challenges caused by the global economic downturn and Pr ... more